{"text_format":"3","workbook":"xls","n_sheets":1,"sheets":["Sheet1"],"not_rendered":{"external_links":1},"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"Sheet1","index":0,"n_rows":49,"n_cols":11,"rows_kept":49,"merged":[[0,0,0,10],[2,0,3,0],[2,1,3,1],[2,2,3,2],[2,3,3,3],[2,4,3,4],[2,5,3,5],[2,9,3,9],[2,10,3,10],[4,0,5,0],[4,1,5,1],[4,2,5,2],[4,3,5,3],[4,4,5,4],[4,5,5,5],[4,8,5,8],[4,9,5,9],[4,10,5,10],[6,0,7,0],[6,1,7,1],[6,2,7,2],[6,3,7,3],[6,4,7,4],[6,5,7,5],[6,9,7,9],[6,10,7,10],[8,0,9,0],[8,1,9,1],[8,2,9,2],[8,3,9,3],[8,4,9,4],[8,5,9,5],[8,9,9,9],[8,10,9,10],[10,0,11,0],[10,1,11,1],[10,2,11,2],[10,3,11,3],[10,4,11,4],[10,5,11,5],[10,9,11,9],[10,10,11,10],[12,0,13,0],[12,1,13,1],[12,2,13,2],[12,3,13,3],[12,4,13,4],[12,9,13,9],[12,10,13,10],[14,0,15,0],[14,1,15,1],[14,2,15,2],[14,3,15,3],[14,4,15,4],[14,9,15,9],[14,10,15,10],[16,0,17,0],[16,1,17,1],[16,2,17,2],[16,3,17,3],[16,4,17,4],[16,5,17,5],[16,9,17,9],[16,10,17,10],[18,0,19,0],[18,1,19,1],[18,2,19,2],[18,3,19,3],[18,4,19,4],[18,5,19,5],[18,8,19,8],[18,9,19,9],[18,10,19,10],[20,0,21,0],[20,1,21,1],[20,2,21,2],[20,3,21,3],[20,4,21,4],[20,8,21,8],[20,9,21,9],[20,10,21,10],[22,0,23,0],[22,1,23,1],[22,2,23,2],[22,3,23,3],[22,4,23,4],[22,5,23,5],[22,9,23,9],[22,10,23,10],[24,0,25,0],[24,1,25,1],[24,2,25,2],[24,3,25,3],[24,4,25,4],[24,5,25,5],[24,9,25,9],[24,10,25,10],[26,0,27,0],[26,1,27,1],[26,2,27,2],[26,3,27,3],[26,4,27,4],[26,5,27,5],[26,9,27,9],[26,10,27,10],[28,0,29,0],[28,1,29,1],[28,2,29,2],[28,3,29,3],[28,4,29,4],[28,5,29,5],[28,8,29,8],[28,9,29,9],[28,10,29,10],[30,0,31,0],[30,1,31,1],[30,2,31,2],[30,3,31,3],[30,4,31,4],[30,9,31,9],[30,10,31,10],[32,0,33,0],[32,1,33,1],[32,2,33,2],[32,3,33,3],[32,4,33,4],[32,9,33,9],[32,10,33,10],[34,0,35,0],[34,1,35,1],[34,2,35,2],[34,3,35,3],[34,4,35,4],[34,5,35,5],[34,8,35,8],[34,9,35,9],[34,10,35,10],[36,0,37,0],[36,1,37,1],[36,2,37,2],[36,3,37,3],[36,4,37,4],[36,8,37,8],[36,9,37,9],[36,10,37,10],[38,0,39,0],[38,1,39,1],[38,2,39,2],[38,3,39,3],[38,4,39,4],[38,5,39,5],[38,8,39,8],[38,9,39,9],[38,10,39,10],[40,0,41,0],[40,1,41,1],[40,2,41,2],[40,3,41,3],[40,4,41,4],[40,5,41,5],[40,9,41,9],[40,10,41,10],[42,0,43,0],[42,1,43,1],[42,2,43,2],[42,3,43,3],[42,4,43,4],[42,9,43,9],[42,10,43,10],[44,0,45,0],[44,1,45,1],[44,2,45,2],[44,3,45,3],[44,4,45,4],[44,5,45,5],[44,9,45,9],[44,10,45,10],[46,0,47,0],[46,1,47,1],[46,2,47,2],[46,3,47,3],[46,4,47,4],[46,5,47,5],[46,9,47,9],[46,10,47,10],[48,0,48,10]],"flags":["formulas_cached_only"]}
["Table 1. Characteristics of included studies."]
["Study","Country or area","Design","Stage (% of patients)","no. of patients","Median age (years)","Adjuvant therapy (n)","Adjuvent regimen","Histology (% of patients)","Median follow-up (months)","Quality assessment*"]
["McEachron 2021","USA","R","ⅢC (100%)",144,"NR","AC (40)","TP; PTC; other","E (17%)",66,7]
[{"$nulls":6},"CCRT (104)","EBRT ± VBT","NE: PSC (37%); SC (42%); CCA (4%)"]
["Montes de Oca 2021","USA","R","ⅢA (100%)",671,58.3,"AC (286)","NR","E (100%)","NR",6]
[{"$nulls":6},"CCRT (385)","EBRT, VBT"]
["Bogani 2020","USA","R","ⅢC (100%)",80,"NR","AC (24)","TC; TP; AP; CP; PTC","E (48%)","NR",7]
[{"$nulls":6},"CCRT (56)","EBRT","NE (52%)"]
["Huang 2020","Taiwan","R","ⅢA (32%), IIIB (62%), IIIC (6%)",125,57,"AC (67)","TP; TC; AC","E: 85%",44,8]
[{"$nulls":6},"CCRT (58)","EBRT, VBT","NE: PSC (10%); CCA (1%); other (2%)"]
["Ko 2020","USA","R","ⅢA (41%), IIIB (17%), IIIC (42%)",1301,73,"AC (779)","TP","E (63%)",43.2,7]
[{"$nulls":6},"CCRT (522)","EBRT, VBT","NE: SC (21%); CCA (4%); CS (12%)"]
["Lee 2020","Taiwan","R","ⅢC (100%)",441,55,"AC (142)","NR","E (82%)",43.2,7]
[{"$nulls":5},57,"CCRT (299)","EBRT","NE (18%)"]
["van Weelden 2020","Netherlands","R","ⅢA (33%), IIIB (8%), IIIC (59%)",333,65.8,"AC (158)","NR","E (36%)","NR",6]
[{"$nulls":5},62.9,"CCRT (175)","EBRT","NE: PSC (40%); CCA (5%); SC (19%)"]
["Verrengia 2020","Italy","R","ⅢA (28%), IIIB (9%), IIIC (63%)",32,"NR","AC (14)","TP","E (72%)",31,6]
[{"$nulls":6},"CCRT (18)","EBRT, VBT","NE (28%)"]
["Kahramanoglu 2019","Central Asia/Eastern Europe","R","ⅢA (32%), IIIB (2%), IIIC (66%)",787,"NR","AC (242)","TC","E (100%)",42,6]
[{"$nulls":6},"CCRT (545)","EBRT±VBT"]
["Kidd 2019","USA","R","ⅢA (23%), IIIB (5%), IIIC (72%)",13072,60,"AC (7847)","NR","E (100%)",44.4,7]
[{"$nulls":5},60,"CCRT (5225)","EBRT"]
["Matei 2019","USA","RCT","ⅢA (21%), IIIB (3%), IIIC (73%), IVA (1%)",736,60,"AC (366)","TP","E (70%)",47,5]
[{"$nulls":6},"CCRT (370)","EBRT","NE: SC (18%); CCA (3%); other (9%)"]
["Syeda 2019","USA","R","ⅢA (17%), IIIB (6%), IIIC (77%)",18456,65,"AC (9456)","NR","E (59%)",39,7]
[{"$nulls":6},"CCRT (9000)","EBRT","NE: PSC (17%); CCA (3%); NOS (21%)"]
["Albuquerque 2018","USA","R","ⅢA (39%), IIIB (8%), IIIC (53%)",181,62,"AC (57)","TP ; AP; PTC","E (66%)",31.5,5]
[{"$nulls":6},"CCRT (124)","EBRT; VBT","NE(34%)"]
["Wang 2018","USA","R","ⅢA-C（NR）",8057,"NR","AC (4834)","NR","E (100%)","NR",5]
[{"$nulls":6},"CCRT (3223)","EBRT ± VBT"]
["Binder 2017","USA","R","ⅢC (100%)",146,67.5,"AC (46)","TP; AC","E (73%)",40.1,8]
[{"$nulls":5},60.5,"CCRT (100)","EBRT, IMRT, VBT","NE: PSC (23%); CCA(14%)"]
["Lester-Coll 2016","USA","R","ⅢA (27%), IIIB (13%), IIIC (60%)",9226,62,"AC (5808)","NR","E: 28%",59.6,7]
[{"$nulls":5},61,"CCRT (3418)","EBRT ± VBT","NE: SC (14%); MCC (15%); CCA (19%); other (24%)"]
["Lin 2016","USA","R","ⅢC (100%)",1807,67,"AC (881)","NR","NE: PSC (100%)",25.8,5]
[{"$nulls":6},"CCRT (926)","EBRT, VBT"]
["Mahdi 2016","USA","R","ⅢA-C（NR）",1838,67,"AC (1272)","TP","NE: SC (100%)","NR",5]
[{"$nulls":5},65,"CCRT (566)","EBRT ± VBT"]
["Signorelli 2015","Italy","R","ⅢA (45%), IIIB (7%), IIIC (48%)",75,61,"AC (46)","AP; PAC; CP; CT; other","E/NE (NR)",101,6]
[{"$nulls":6},"CCRT (29)","EBRT"]
["Kuku 2013","UK","R","ⅢA (60%), IIIB (10%), IIIC (30%)",58,67,"AC (7)","TP","E (65%)",58,7]
[{"$nulls":6},"CCRT (51)","EBRT ± VBT","NE: PSC (16%); CCA (4.3%); MCC (5.3%); other (9.4%)"]
["Secord 2013","USA","R","ⅢC (100%)",207,61,"AC (46)","TP; AP; PTC; CT; other","E (66%)",42,6]
[{"$nulls":5},60,"CCRT (161)"," WPRT; WAR; VBT","NE: PSC (11%); MCC (18%); other (5%)"]
["Marchetti 2011","Italy","R","ⅢA (51%), IIIB (2%), IIIC (47%)",60,62,"AC (41)","TP; TC; AP; AC; only P","E (80%)",37,7]
[{"$nulls":6},"CCRT (19)","EBRT ± VBT","NE: PSC (15%); CCA (3%); other (2%)"]
["Havrilesky 2009","USA","R","ⅢA (100%)",38,64,"AC (19)","AP; TC; TP","E (71%)",52.8,6]
[{"$nulls":6},"CCRT (19)","WPRT, WAR, VBT, ","NE (29%): PSC, CCA, MCC"]
["Abbreviations : R, retrospective; E, endometroid; NE, non-endometroid; AC, adjuvant chemotherapy; CCRT, chemoradiotherapy; N, number of all patients; CCA, clear cell carcinoma; CS, carcinosarcoma; PSC, papillary serous carcinoma; SC: serous carcinoma; MCC: mixed-cell carcinoma; UNC, uterine neuroendocrine carcinoma; LS, Leiomyosarcoma; UN, undifferentiated; NOS, unknown; T, Taxol; A, Adriamycin; P, platinum; TC, Taxol+ cisplatin; TP, Taxol+ carboplatin; PC, carboplatin+ cyclophosphamide; AP, Adriamycin+ cisplatin; AC, Adriamycin+ carboplatin; PAC, Adriamycin+ cyclophosphamide+ cisplatin; CP, cyclophosphamide+ cisplatin; PTC, platinum+ Taxol+ Adriamycin; CT, Taxol only; EBRT: external pelvic radiotherapy; VBT: vaginal brachytherapy; IMRT: image-guidance or intensity-modulated radiation therapy; WAR: whole abdominal radiotherapy; WPRT: whole pelvic radiotherapy. ⁎ Cohort studies were measured by the Newcastle-Ottawa Quality Assessment Scale (NOS) and RCT was measured by jaded/Oxford."]